New usage paradigms in antibody therapy: Induction or true prophylaxis?

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 1234-1235

  Kirkman, R L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY; STEROID;

CONFERENCE PAPER; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROPHYLAXIS; RAT; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; MODELS, IMMUNOLOGICAL; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; TRANSPLANTATION IMMUNOLOGY;

EID: 0032988139     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01976-9     Document Type: Conference Paper

References (7)

1. Queen C., Schneider W.P., Selick H.E., et al. Proc Natl Acad Sci USA. 86:1989;10029.
2. Amlot P.L., Rawlings E., Fernando O.N., et al. Transplantation. 60:1995;748.
3. Vincenti F., Kirkman R., Light S., et al. N Engl J Med. 338:1998;161.
4. Nashan B., Moore R., Amlot P., et al. Lancet. 350:1997;1193.
5. Kovarik J., Wolf P., Cisterne J.M., et al. Transplantation. 64:1997;1701.
6. Kirkman R.L., Barrett L.V., Gaulton G.N., et al. J Exp Med. 162:1985;358.
7. Kirkman R.L., Shapiro M.E., Carpenter C.B., et al. Transplantation. 51:1991;107.